Does this patient have Parkinson disease?
- PMID: 12525236
- DOI: 10.1001/jama.289.3.347
Does this patient have Parkinson disease?
Abstract
Context: Diagnosis of Parkinson disease (PD) remains challenging. An accurate diagnosis is important because effective symptomatic treatment for PD is available.
Objective: To systematically review the literature for information on the precision and accuracy of the clinical examination for diagnosing PD.
Data sources: MEDLINE database was searched for all English-language articles related to the diagnosis of PD published from January 1966 through April 2001. The reference lists of all articles retrieved were searched for additional relevant sources.
Study selection: Studies in which patients presented with 1 or more typical features of PD were included if the final diagnosis was confirmed by a suitable criterion standard and data could be extracted to determine the accuracy of 1 or more symptoms or signs. Variability in descriptions of symptoms and signs made it impossible to combine data across existing studies for most findings.
Data synthesis: We identified 6 studies that met our criteria. The positive (presence) likelihood ratios (LRs) for tremor as a symptom of PD ranged from 1.3 to 17 (range of negative [absence] LRs, 0.24 to 0.60). Tremor as a sign of PD produced a range of positive LRs from 1.3 to 1.5 (negative LRs, 0.47 to 0.61). Clinical features useful in the diagnosis of PD include a history of the combination of symptoms of rigidity and bradykinesia (positive LR, 4.5; negative LR, 0.12); a history of loss of balance (range of positive LRs, 1.6 to 6.6; range of negative LRs, 0.29 to 0.35), symptoms of micrographia (range of positive LRs, 2.8 to 5.9; range of negative LRs, 0.30 to 0.44), and a history of shuffling gait (range of positive LRs, 3.3 to 15; range of negative LRs, 0.32 to 0.50). Trouble with certain tasks such as turning in bed (positive LR, 13; negative LR, 0.56), opening jars (positive LR, 6.1; negative LR, 0.26), and rising from a chair (range of positive LRs, 1.9 to 5.2; range of negative LRs, 0.39 to 0.58). Useful signs include the glabella tap test (positive LR, 4.5; negative LR, 0.13), difficulty walking heel-to-toe (positive LR, 2.9; negative LR, 0.32), and rigidity (range of positive LRs, 0.53 to 2.8; range of negative LRs, 0.38 to 1.6). Significant selection bias was detected in all studies included for review.
Conclusions: Symptoms of tremor, rigidity, bradykinesia, micrographia, shuffling gait, and difficulty with the tasks of turning in bed, opening jars, and rising from a chair should be carefully reviewed in all patients with suspected PD. The glabella tap and heel-to-toe tests also should be assessed.
Similar articles
-
Using wearables to assess bradykinesia and rigidity in patients with Parkinson's disease: a focused, narrative review of the literature.J Neural Transm (Vienna). 2019 Jun;126(6):699-710. doi: 10.1007/s00702-019-02017-9. Epub 2019 May 22. J Neural Transm (Vienna). 2019. PMID: 31115669
-
QAPD: an integrated system to quantify symptoms of Parkinson's disease.Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:1822-1825. doi: 10.1109/EMBC.2016.7591073. Annu Int Conf IEEE Eng Med Biol Soc. 2016. PMID: 28268681
-
Does this patient have myasthenia gravis?JAMA. 2005 Apr 20;293(15):1906-14. doi: 10.1001/jama.293.15.1906. JAMA. 2005. PMID: 15840866 Review.
-
Does this adult patient have early HIV infection?: The Rational Clinical Examination systematic review.JAMA. 2014 Jul 16;312(3):278-85. doi: 10.1001/jama.2014.5954. JAMA. 2014. PMID: 25027143 Review.
-
Does this child have acute otitis media?JAMA. 2003 Sep 24;290(12):1633-40. doi: 10.1001/jama.290.12.1633. JAMA. 2003. PMID: 14506123 Review.
Cited by
-
Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.Int J Mol Sci. 2023 May 22;24(10):9105. doi: 10.3390/ijms24109105. Int J Mol Sci. 2023. PMID: 37240451 Free PMC article.
-
Abécédaire de la maladie de Parkinson, partie 1 : le diagnostic.Can Fam Physician. 2023 Jan;69(1):e8-e13. doi: 10.46747/cfp.6901e8. Can Fam Physician. 2023. PMID: 36693748 Free PMC article. French.
-
Parkinson disease primer, part 1: diagnosis.Can Fam Physician. 2023 Jan;69(1):20-24. doi: 10.46747/cfp.690120. Can Fam Physician. 2023. PMID: 36693741 Free PMC article.
-
A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson's Disease.Int J Mol Sci. 2021 Nov 11;22(22):12198. doi: 10.3390/ijms222212198. Int J Mol Sci. 2021. PMID: 34830081 Free PMC article. Review.
-
Exploring Test-Retest Reliability and Longitudinal Stability of Digital Biomarkers for Parkinson Disease in the m-Power Data Set: Cohort Study.J Med Internet Res. 2021 Sep 13;23(9):e26608. doi: 10.2196/26608. J Med Internet Res. 2021. PMID: 34515645 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
